BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee SY, Seo HJ, Kim S, Eo JS, Oh SC. Prognostic significance of interim 18 F-fluorodeoxyglucose positron emission tomography-computed tomography volumetric parameters in metastatic or recurrent gastric cancer. Asia Pac J Clin Oncol 2018;14:e302-9. [PMID: 29226597 DOI: 10.1111/ajco.12833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Tang L, Wang XJ, Baba H, Giganti F. Gastric cancer and image-derived quantitative parameters: Part 2-a critical review of DCE-MRI and 18F-FDG PET/CT findings. Eur Radiol 2020;30:247-60. [PMID: 31392480 DOI: 10.1007/s00330-019-06370-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
2 Mi L, Zhao Y, Zhao X, Yin F, Yin X, Li N, Shi J, Han X, Duan X, Zhao M, Han G, Wang J. 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Metabolic Parameters Before and After Neoadjuvant Chemotherapy Can Predict the Postoperative Prognosis of Locally Advanced Gastric Cancer. Cancer Biother Radiopharm 2021;36:662-71. [PMID: 32783634 DOI: 10.1089/cbr.2020.3942] [Reference Citation Analysis]
3 Yoo SH, Kang SY, Yoon J, Kim TY, Cheon GJ, Oh DY. Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy. Sci Rep 2021;11:296. [PMID: 33436659 DOI: 10.1038/s41598-020-78963-2] [Reference Citation Analysis]
4 Yoo SH, Choi W, Kim Y, Kim MS, Park HY, Keam B, Heo DS. Difficulties Doctors Experience during Life-Sustaining Treatment Discussion after Enactment of the Life-Sustaining Treatment Decisions Act: A Cross-Sectional Study. Cancer Res Treat 2021;53:584-92. [PMID: 33211941 DOI: 10.4143/crt.2020.735] [Reference Citation Analysis]